Drug Interactions in the Treatment of Patients with Parkinson’s Disease - LimitingFactor of Successful Treatment
Lékové interakce při léčběparkinsoniků - limitující faktorúspěšné léčby
Přehledný článek uvádí možné interakce mezi léky užívanými k léčbě parkinsoniků (např.preparáty L-Dopa, neuroleptika apod.) a uvádí také řadu nevhodných léčebných kombinací.
Klíčová slova:
Parkinsonova nemoc - terapie - interakce léků - L-Dopa - neuroleptika.
Authors:
J. Fiedler
Authors‘ workplace:
Neurologická klinika FN, Plzeň, přednosta prof. MUDr. Z. Ambler, DrSc.
Published in:
Prakt. Lék. 1999; (2): 96-97
Category:
Overview
The submitted review deals with possible interactions between drugs used for treatment ofpatients with Parkinson’s disease (e.g. L-Dopa, neuroleptic drugs etc.) and the author mentionsalso some unsuitable therapeutic combinations.
Key words:
Parkinson’s disease - therapy - drug interactions - L-Dopa - neuroleptics.
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
1999 Issue 2
- Definition and Classification of Chronic Kidney Disease According to KDIGO
- Doc. Jiří Kubeš: The major benefit of proton therapy lies in protecting healthy tissues
- Minimally Invasive Treatment of Pilonidal Sinus: Laser and Negative Pressure Therapy as a Gentle and Effective Modality
- Trazodone as an Effective Medicine in the Therapy of Depression and Insomnia
- Diagnosis of Cow Milk Protein Allergy − Current Methods and Their Diagnostic Value
Most read in this issue
- Systemic Complications in Acute Yersiniosis
- Electroconvulsive Treatment - Pitfalls of Administration inExtreme Age Groups
- Economics of the Health Services. III. Introduction to Microeconomics ofthe Health Services
- Hormone Therapy in Transsexual Subjects